Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEES
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,746
Award facts
- Contract value 100% obligated
- $16,745.74 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,745.74 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 16, 2025, is placed against DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to supply Department of Defense military healthcare facilities worldwide with comprehensive pharmaceutical products and medical consumables. DMS Pharmaceutical Group was awarded its underlying IDC on November 13, 2025, with a $499,999,999 ceiling value and a completion date of December 31, 2036. This contract was not issued under a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group's product portfolio under this arrangement encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables, including oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals. As a critical supplier within the federal pharmaceutical supply chain, the company leverages its small business status and established performance track record to fulfill the diverse and specialized medical supply needs of the military healthcare system. No subcontractor relationships are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FEEES?
SPE2DU26FEEES was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DU26FEEES worth?
The government has obligated $16,746 on SPE2DU26FEEES.
Is contract SPE2DU26FEEES an order under another contract?
Yes. SPE2DU26FEEES is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEES competed?
The extent of competition for SPE2DU26FEEES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award